Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

BI-671800

Generic Name: BI-671800

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₆F_₃N_₅O_₃

CAS Number: 1093108-50-9

Unique Ingredient Identifier: 721F767LHB

Overview

Bi 671800 has been used in trials studying the treatment of Asthma and Rhinitis, Allergic, Perennial.

Background

Bi 671800 has been used in trials studying the treatment of Asthma and Rhinitis, Allergic, Perennial.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Pharmacokinetics, Safety and Tolerability of BI 671800 HEA Given Over 7 Days. A Randomised, Double Blind, Placebo Controlled Within Dose Groups Phase I Study in Healthy Male and Female Volunteers.

Phase 1

Completed

Posted: 2010/10/07

Sponsor:Boehringer Ingelheim

ID:NCT01215773

Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers

Phase 1

Completed

Posted: 2010/10/07

Sponsor:Boehringer Ingelheim

ID:NCT01216384

A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers

Phase 1

Completed

Posted: 2010/09/20

Sponsor:Boehringer Ingelheim

ID:NCT01205373

BI 671800 in Asthmatic Patients on Inhaled Corticosteroids

Phase 2

Completed

Posted: 2010/04/14

Sponsor:Boehringer Ingelheim

ID:NCT01103349

BI 671800 ED in Steroid-naive Asthmatic Patients

Phase 2

Completed

Posted: 2010/03/24

Sponsor:Boehringer Ingelheim

ID:NCT01092143

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy